Evidence map›Paper›PMID 28634408›Full record

ArticleScientific reports2017

A tightly regulated IL-22 response maintains immune functions and homeostasis in systemic viral infection.

Panpan Yi, Yuejin Liang, Denley Ming Kee Yuan, Zuliang Jie, Zakari Kwota, Yan Chen, Yingzi Cong, Xuegong Fan, Jiaren Sun

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Frontiers in immunology · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Interleukin-22 Influences the Th1/Th17 Axis.Frontiers in immunology · 2021
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Panpan YiDepartment of Infectious Diseases, Key Laboratory of Viral Hepatitis of Hunan, Xiangya Hospital, Central South University, Hunan, China.
Yuejin LiangDepartment of Microbiology and Immunology, University of Texas Medical Branch, Texas, USA.
Denley Ming Kee YuanDepartment of Microbiology and Immunology, University of Texas Medical Branch, Texas, USA.
Zuliang JieDepartment of Microbiology and Immunology, University of Texas Medical Branch, Texas, USA.
Zakari KwotaDepartment of Microbiology and Immunology, University of Texas Medical Branch, Texas, USA.
Yan ChenDepartment of Ophthalmology, University of Texas Medical Branch, Texas, USA.
Yingzi CongDepartment of Microbiology and Immunology, University of Texas Medical Branch, Texas, USA.
Xuegong FanDepartment of Infectious Diseases, Key Laboratory of Viral Hepatitis of Hunan, Xiangya Hospital, Central South University, Hunan, China. xgfan@hotmail.com.
Jiaren SunDepartment of Microbiology and Immunology, University of Texas Medical Branch, Texas, USA. jisun@utmb.edu.
The University of Texas Medical Branch at Galveston · USCentral South University · CNXiangya Hospital Central South University · CN

Funding

mTORC1-TFEB pathway in degeneration of the RPER01EY026999 · NEI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI CHEN, YAN · 2016 to 2025
$3.4M
Infectious Diseases and Inflammatory Disorders Training ProgramT35AI078878 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI WANG, TIAN · 2008 to 2025
$701k
Retinoic Acid Regulates S100 Proteins and Immune Responses in Viral HepatitisR21AI126371 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI SUN, JIAREN · 2016 to 2017
$426k
Damage-associated Alarmin Key to Immune Responses in Viral HepatitisR21AI109100 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI SUN, JIAREN · 2014 to 2015
$426k
NEI NIH HHS R01 EY026999NIAID NIH HHS R21 AI109100NIAID NIH HHS R21 AI126371NIAID NIH HHS T35 AI078878
6 · The paper itself

Abstract

Interleukin-22 (IL-22) plays an important role in host immunity and tissue homeostasis in infectious and inflammatory diseases. However, the function and regulation of IL-22 in viral infection remain largely unknown. Here, we report that viral infection triggered early IL-22 production from the liver and lymphoid organs. γδ T cells are the main immune cells to produce IL-22 in the liver, a process mediated by the IL-23/phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin complex 1 (mTORC1) signaling pathway. In the presence of IL-23, IL-22 production is independent of aryl hydrocarbon receptor (AhR) signaling. In acute and persistent viral infections, IL-22 deficiency resulted in thymic and splenic hypertrophy, while excessive IL-22 induced atrophy in these lymphoid organs. Moreover, IL-22 deficiency enhanced T cell responses to promote viral clearance, but increased IL-22 in vivo decreased T cell numbers and functions in the liver and lymphoid tissues. Together, our findings reveal a significant effect of the IL-23/PI3K/mTORC1 axis on regulating IL-22 production and also identify a novel role of IL-22 in controlling antiviral T cell responses in the non-lymphoid and lymphoid organs during acute and persistent viral infections.

Indexed as

HomeostasisAnimalsHost-Pathogen InteractionsInterleukin-22InterleukinsMicePhosphatidylinositol 3-KinasesReceptors, Antigen, T-Cell, gamma-deltaSignal TransductionT-LymphocytesTOR Serine-Threonine KinasesVirus DiseasesInterleukin-22InterleukinsPhosphatidylinositol 3-KinasesReceptors, Antigen, T-Cell, gamma-deltaTOR Serine-Threonine Kinases

Identifiers

PMID28634408
PMCPMC5478593
OpenAlexW2628654901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.